Insider Transactions in Q3 2024 at Keros Therapeutics, Inc. (KROS)

KROS Quotes by TradingView

Insider Transaction List (Q3 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Aug 13 2024
Carl L Gordon Director
SELL
Open market or private sale
Indirect
250,000 -19.72%
$11,000,000 $44.01 P/Share
Aug 13 2024
Orbimed Advisors LLC Director
SELL
Open market or private sale
Indirect
250,000 -19.72%
$11,000,000 $44.01 P/Share

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KROS